P1158: REAL-WORLD PATIENT CHARACTERISTICS, TREATMENT PATTERNS, AND TREATMENT OUTCOMES OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) BY LINE OF THERAPY (LOT)
Helmneh Sineshaw,
Christina Zettler,
Jennifer Prescott,
Mahek Garg,
Samhita Chakraborty,
Eric Sarpong,
Andrew Belli,
Claire Bai,
Ching-Kun Wang
Affiliations
Helmneh Sineshaw
1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Christina Zettler
2 Cota, Inc, New York, United States
Jennifer Prescott
1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Mahek Garg
1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Samhita Chakraborty
1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
Eric Sarpong
1 Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
